TAZEMETOSTAT HYDROBROMIDE for Brain neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 31 adverse event reports in the FDA FAERS database where TAZEMETOSTAT HYDROBROMIDE was used for Brain neoplasm malignant.
Most Reported Side Effects for TAZEMETOSTAT HYDROBROMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 298 | 22.5% | 60 | 48 |
| Fatigue | 292 | 22.1% | 10 | 41 |
| Disease progression | 267 | 20.2% | 44 | 44 |
| Nausea | 207 | 15.7% | 12 | 31 |
| Product dose omission issue | 183 | 13.8% | 4 | 32 |
| Death | 106 | 8.0% | 105 | 27 |
| Diarrhoea | 100 | 7.6% | 2 | 11 |
| Decreased appetite | 81 | 6.1% | 4 | 17 |
| Asthenia | 75 | 5.7% | 5 | 29 |
| Vomiting | 75 | 5.7% | 8 | 16 |
| Constipation | 66 | 5.0% | 2 | 5 |
| Covid-19 | 65 | 4.9% | 4 | 30 |
| Alopecia | 61 | 4.6% | 2 | 8 |
| Headache | 61 | 4.6% | 3 | 5 |
| Pain | 58 | 4.4% | 5 | 17 |
Other Indications for TAZEMETOSTAT HYDROBROMIDE
Follicular lymphoma (439)
Soft tissue sarcoma (298)
Off label use (102)
B-cell lymphoma (91)
Malignant connective tissue neoplasm (72)
Product used for unknown indication (54)
Epithelioid sarcoma (46)
Follicular lymphoma stage ii (38)
Follicular lymphoma stage i (34)
Neoplasm malignant (23)
Other Drugs Used for Brain neoplasm malignant
PROCARBAZINE (2,283)
TEMOZOLOMIDE (2,202)
BEVACIZUMAB (740)
TRAMETINIB DIMETHYL SULFOXIDE (317)
LOMUSTINE (291)
THALIDOMIDE (195)
DABRAFENIB (189)
IVOSIDENIB (140)
SELINEXOR (136)
AVAPRITINIB (122)